Maculopathy and vasculitis associated with dengue in a young patient
DOI:
https://doi.org/10.70313/2718.7446.v17.n01.291Keywords:
dengue, maculopathy, retinal vasculitis, inflammatory infiltrates, virusesAbstract
The dengue virus is an arbovirus of the Flaviviridae family. The Aedes aegypti mosquito is its main vector. The clinical presentation of dengue varies from a febrile illness to life-threatening dengue shock syndrome. The main symptom of dengue is fever that lasts 3 to 7 days. Traditionally, it has been thought that ocular pathology in dengue is rare, although its involvement is increasingly recognized. The objective of this article is to report the case of a patient who presented bilateral dengue maculopathy associated with vasculitis. A 32-year-old male patient with decreased vision of 48 hours of evolution. The only history was that he had been diagnosed with dengue fever 5 days before. The fundus examination revealed perivascular inflammation and discoloration changes in the macular area of both eyes. On OCT, inflammatory infiltrates were observed in the middle layers of the retina of both eyes. After one month, the patient recovered his total visual acuity and the retinal signs completely resolved under treatment with oral meprednisone every 12 hours and topical treatment with prednisolone every 8 hours. Currently there is no established treatment for dengue maculopathy. Active monitoring of the patient is required. Most lesions resolve spontaneously. But topical and systemic corticosteroids and immunomodulators can also be considered for treatment.
Downloads
References
World Health Organization (WHO). Dengue and severe dengue [en línea]. Geneva: WHO, March 17, 2023. Disponible en: https://www.who.int/en/news-room/fact-sheets/detail/dengue-and-severe-dengue
Tan W, Liew JWK, Selvarajoo S et al. Inapparent dengue in a community living among dengue-positive Aedes mosquitoes and in a hospital in Klang Valley, Malaysia. Acta Trop 2020; 204: 105330.
Centers for Disease Control and Prevention. Dengue: with or without warning signs [en línea]. Atlanta: Centers for Disease Control and Prevention. Disponible en: https://www.cdc.gov/dengue/training/cme/ccm/page47831.html
Chan DPL, Teoh SCB, Bronceado CSH et al. Ophthalmic complications of dengue. Emerging Infect Dis 2006; 12: 285-289. Disponible en: https://wwwnc.cdc.gov/eid/article/12/2/05-0274_article
Ng W, Teoh SC. Dengue eye disease. Surv Ophthalmol 2015; 60: 106-114.
Koundanya VV, Chowdhary N, Agarwal M, Katre P. Secondary dengue retinitis with associated occlusive retinal vasculitis. J Ophthalmic Inflamm Infect 2019; 9: 7.
Ng CWK, Tai PY, Mohamed SO. Dengue maculopathy associated with choroidopathy and pseudohypopyon: a case series. Ocul Immunol Inflamm 2018; 26: 666-670.
Rudzinski M, Echeverria AE. Ocular inflammatory manifestations induced by dengue virus infection. Oftalmol Clin Exp 2020; 13: 113-126.
Cherng-Hui Yip V, Sanjay S, Koh YT. Ophthalmic complications of dengue fever: a systematic review. Ophthalmol Ther 2012; 1: 2.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Consejo Argentino de Oftalmología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Con esta licencia no se permite un uso comercial de la obra original, ni la generación de obras derivadas. Las licencias Creative Commons permiten a los autores compartir y liberar sus obras en forma legal y segura.